New research has found specialist nursing support for Australian men on hormone therapies for prostate cancer may help to reduce higher risks of suicide and improve quality of life for men impacted by the disease.
In Australia, Prostate cancer (PCa) has a high survival rate (96%) meaning men with PCa may live with the impact of the disease for many years, even decades. The Prostate Cancer Foundation of Australia (PCFA) manages two Prostate Cancer Specialist Nursing (PCSN) programs: (1) A health service-based program and (2) A telenursing service. There is a paucity of economic evidence regarding the benefits of these programs so Social Return on Investment (SROI) methodology was used to determine social value and return on investment.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
Cancer Council has updated cancer publications: Understanding Primary Bone Cancer, Nutrition and Cancer, Understanding Testicular Cancer, Sex, Intimacy & Cancer.
